If demography is destiny, then it appears that destiny for Europe includes a rapidly ageing population, increasing economic, social and healthcare burdens and a weakening position on the world stage. Governments are waking up to the need to address the demographic shift, but, so far, have not discovered the ideal mix for an effective population policy. This documented briefing details the results of a preliminary investigation into whether Assisted Reproductive Technologies can play a part in preventing European countries from falling into the low fertility trap.
The research described in this report was funded through a research grant from Ferring Pharmaceuticals and was conducted by RAND Europe.
This report is part of the RAND Corporation documented briefing series. RAND documented briefings are based on research presented to a client, sponsor, or targeted audience in briefing format. Additional information is provided in the documented briefing in the form of the written narration accompanying the briefing charts. All RAND documented briefings undergo rigorous peer review to ensure that they meet high standards for research quality and objectivity. However, they are not expected to be comprehensive and may present preliminary findings. Major research findings are published in the monograph series; supporting or preliminary research is published in the technical report series.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.